Group 1 - The company Hendy Pharmaceutical (301211.SZ) announced that shareholder Jingmen Ningkang Enterprise Management Center (Limited Partnership) plans to reduce its holdings by up to 4.176 million shares, accounting for 1% of the total share capital, within three months after fifteen trading days from the announcement date [1] - Shareholder Jingmen Beikang Enterprise Management Center (Limited Partnership) intends to reduce its holdings by up to 1.392 million shares, representing 0.33% of the total share capital, within the same timeframe [1] - Shareholder Lei Xiaoyan plans to reduce her holdings by up to 4.176 million shares, also accounting for 1% of the total share capital, within three months after three trading days from the announcement date [1]
亨迪药业：三股东拟减持合计不超2.33%股份